trending Market Intelligence /marketintelligence/en/news-insights/trending/apm4hxboiiqwleg0imtjgg2 content esgSubNav
In This List

BioTime director to step down

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


BioTime director to step down

BioTime Inc. said David Schlachet will step down from the company's board of directors and will not seek reelection at the company's 2018 annual meeting.

Schlachet's decision to step down was due to the logistics of being a director of the company while living in Israel. He will remain a director of Cell Cure Neurosciences Ltd., an Israel-based unit of BioTime.

The Alameda, Calif.-based company develops therapies for degenerative diseases.